HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 357 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38 | +11.8% | 327 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $34 | -15.0% | 327 | -10.9% | 0.00% | 0.0% |
Q1 2023 | $40 | -92.4% | 367 | -92.0% | 0.00% | -92.6% |
Q4 2022 | $523 | -99.8% | 4,600 | 0.0% | 0.03% | +68.8% |
Q3 2022 | $285,000 | -22.3% | 4,600 | 0.0% | 0.02% | -15.8% |
Q2 2022 | $367,000 | -34.5% | 4,600 | -13.6% | 0.02% | -20.8% |
Q1 2022 | $560,000 | -2.3% | 5,327 | 0.0% | 0.02% | +9.1% |
Q4 2021 | $573,000 | -11.7% | 5,327 | -10.1% | 0.02% | -21.4% |
Q3 2021 | $649,000 | +16.9% | 5,927 | 0.0% | 0.03% | +12.0% |
Q2 2021 | $555,000 | +1.6% | 5,927 | 0.0% | 0.02% | -10.7% |
Q1 2021 | $546,000 | -35.9% | 5,927 | -49.1% | 0.03% | -40.4% |
Q4 2020 | $852,000 | +140.0% | 11,650 | +154.6% | 0.05% | +104.3% |
Q3 2020 | $355,000 | +144.8% | 4,576 | +75.9% | 0.02% | +109.1% |
Q2 2020 | $145,000 | +34.3% | 2,602 | -28.3% | 0.01% | +22.2% |
Q1 2020 | $108,000 | -52.6% | 3,630 | -42.4% | 0.01% | -43.8% |
Q4 2019 | $228,000 | – | 6,299 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |